Key Insights

Highlights

Treatment Research

1 treatments under study, led by Smofkabiven

Research Leaders

10 sponsors active, led by Nordsjaellands Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Smofkabiven1

Active Sponsors

  • Nordsjaellands Hospital1
  • Slagelse Sygehus1
  • Copenhagen University Hospital at Herlev1
  • Gødstrup Hospital1
  • Aalborg University Hospital1

Top Investigators

Related Conditions

  • Laparotomy1
  • Ischemia Mesenteric1
  • Bowel Obstruction1

Activity Timeline